Aortic Stenosis Market: Industry Analysis, Epidemiology, Pipeline, Drugs and Companies by DelveInsight

Posted on
by

Aortic Stenosis Market: Industry Analysis, Epidemiology, Pipeline, Drugs and Companies by DelveInsight
Aortic Stenosis Market

Aortic stenosis is the obstruction of blood flow across the aortic valve. Among symptomatic patients with medically treated moderate-to-severe aortic stenosis, mortality from the onset of symptoms is approximately 25% at 1 year and 50% at 2 years. Symptoms of aortic stenosis usually develop gradually after an asymptomatic latent period of 10-20 years.

 

DelveInsight’s ‘‘Aortic Stenosis Market Insights, Epidemiology and Market Forecast-2030’’ report delivers an in-depth understanding of the Aortic Stenosis, historical and forecasted epidemiology as well as the Aortic Stenosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some key facts of Aortic Stenosis Market:

  • As per a study by Pujari et al. (2021), the prevalence of calcific aortic stenosis is about 1% to 2% in patients aged 65 or more, 12% in patients aged 65 or more, and about 3.4% of patients aged greater than 75 have severe aortic stenosis.
  • The prevalence of aortic sclerosis ranges from 9-45% in patients with a mean age of 54 to 81 and increases with age.
  • According to a journal, the prevalence in Japan of any valve disease is 2.5%. Of those with valve disease, about 0.4% have aortic stenosis.
  • According to Grave et al. (2020), in 2017, the guidelines of the European Society of Cardiology and the European Association for Cardio‐Thoracic Surgery recommended SAVR or TAVI, depending on symptoms, AS severity, comorbidities, and the clinical evaluation of the heart team.
  •  

Scope of the Aortic Stenosis Market Report:

  • The report covers the descriptive overview of Aortic Stenosis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Aortic Stenosis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Aortic Stenosis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Aortic Stenosis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Aortic Stenosis market

 

Request for Sample Page: https://www.delveinsight.com/sample-request/aortic-stenosis-market

 

Some of Aortic Stenosis Companies are:

  • MyoKardia
  • And Many Others

 

Aortic Stenosis therapies are:

  • Mavacamten
  • And Many Others

 

Request for Sample Page: https://www.delveinsight.com/sample-request/aortic-stenosis-market

 

Table of contents:

1. Key Insights

2. Executive Summary of Aortic Stenosis

3. Competitive Intelligence Analysis for Aortic Stenosis

4. Aortic Stenosis: Market Overview at a Glance

4.1. Aortic Stenosis Total Market Share (%) Distribution in 2018

4.2. Aortic Stenosis Total Market Share (%) Distribution in 2030

5. Aortic Stenosis: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms

5.3. Pathophysiology

5.4. Risk Factors

5.5. Diagnosis

6. Patient Journey

7. Aortic Stenosis Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Aortic Stenosis Epidemiology Scenario in the 7MM (2018-2030)

7.4. United States Epidemiology

7.4.1. Aortic Stenosis Epidemiology Scenario in the United States (2018-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Aortic Stenosis Epidemiology Scenario in Germany (2018-2030)

7.5.2. France Epidemiology

7.5.2.1. Aortic Stenosis Epidemiology Scenario in France (2018-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Aortic Stenosis Epidemiology Scenario in Italy (2018-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Aortic Stenosis Epidemiology Scenario in Spain (2018-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Aortic Stenosis Epidemiology Scenario in the United Kingdom (2018-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Aortic Stenosis Epidemiology Scenario in Japan (2018-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Aortic Stenosis Treatment and Management

8.2. Aortic Stenosis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Aortic Stenosis Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Aortic Stenosis: Seven Major Market Analysis

13.1. Key Findings

13.2. Aortic Stenosis Market Size in 7MM

13.3. Aortic Stenosis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Aortic Stenosis Total Market Size in the United States

15.1.2. Aortic Stenosis Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Aortic Stenosis Total Market Size in Germany

15.3.2. Aortic Stenosis Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Aortic Stenosis Total Market Size in France

15.4.2. Aortic Stenosis Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Aortic Stenosis Total Market Size in Italy

15.5.2. Aortic Stenosis Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Aortic Stenosis Total Market Size in Spain

15.6.2. Aortic Stenosis Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Aortic Stenosis Total Market Size in the United Kingdom

15.7.2. Aortic Stenosis Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Aortic Stenosis Total Market Size in Japan

15.8.3. Aortic Stenosis Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Aortic Stenosis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

Request for Detailed TOC: https://www.delveinsight.com/sample-request/aortic-stenosis-market

 

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/aortic-stenosis-market